Immedica Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Immedica Pharma's estimated annual revenue is currently $28.1M per year.
- Immedica Pharma's estimated revenue per employee is $201,000
Employee Data
- Immedica Pharma has 140 Employees.
- Immedica Pharma grew their employee count by 27% last year.
Immedica Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $17.1M | 85 | -21% | N/A | N/A |
#2 | $99.7M | 496 | 22% | N/A | N/A |
#3 | $22.9M | 114 | -67% | N/A | N/A |
#4 | $27.3M | 136 | 7% | N/A | N/A |
#5 | $20.9M | 104 | 28% | N/A | N/A |
#6 | $103.1M | 513 | 4% | N/A | N/A |
#7 | $9.4M | 47 | 2% | N/A | N/A |
#8 | $2.4M | 12 | -20% | N/A | N/A |
#9 | $28.1M | 140 | 27% | N/A | N/A |
#10 | $5M | 25 | 4% | N/A | N/A |
What Is Immedica Pharma?
About Immedica Pharma Immedica is a fast-growing private niche pharma group. Its headquarter is based in Stockholm, Sweden, and it has commercial coverage across Europe and the Middle East. Immedica provides significant know-how and experience from commercialization of niche/specialty care products across Europe and the Middle East, and the company's management team has an outstanding track record of operating niche pharma products internationally. Immedica has capabilities to provide optimal access of specialty care medicines to patients with significant medical needs, including key areas such as regulatory affairs, pharmacovigilance, medical affairs, pricing & reimbursement, quality and product distribution. Immedica's main owner is Impilo AB, a private Nordic investment company established in 2017, with more than SEK 3.6 billion in committed capital from leading Nordic and international investors. More information is available at www.immedica.com
keywords:N/A
N/A
Total Funding
140
Number of Employees
$28.1M
Revenue (est)
27%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Immedica Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Global Regulatory Affairs Manager | Reveal Email/Phone |
2 | Head Accounting and Reporting | Reveal Email/Phone |
3 | Senior QA Manager | Reveal Email/Phone |
4 | Head Specialty Care | Reveal Email/Phone |
5 | Supply Chain Manager | Reveal Email/Phone |
6 | CFO | Reveal Email/Phone |
7 | Country Lead Denmark | Reveal Email/Phone |
8 | Head Northern & Southern Europe | Reveal Email/Phone |
9 | Regional Director / General Manager UK & Ireland | Reveal Email/Phone |
10 | Accountant | Reveal Email/Phone |
Immedica Pharma News
Immedica is a fast-growing private niche pharma group with its headquarter in Stockholm, Sweden, and commercial coverage across Europe and the...
Clinical-stage biotech Actinium Pharmaceuticals (NYSE:ATNM) and Swedish pharma group, Immedica Pharma AB announced an agreement for Iomab-B,...
Actinium Pharmaceuticals Inc. shares were 20% higher to $6.33 ... in a commercialization agreement with Immedica Pharma AB for Iomab-B for...
Other Companies in Stockholm
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $22.3M | 140 | 17% | N/A |
#2 | $34.6M | 143 | 22% | N/A |
#3 | N/A | 144 | 6% | N/A |
#4 | $22.3M | 144 | 5% | N/A |
#5 | $26M | 145 | 25% | N/A |